ZEB1 and colorectal carcinoma: H19 was proved to be a novel regulator of EMT in CRC cells, interfering with the expression of H19 can significantly inhibit the expression of mesenchymal core marker gene vimentin, ZEB1 and ZEB2 in CRC cells [21].